详情页 - 河北医科大学第四医院机构库

当前位置：首页 > 详情页

A single-arm, phase II, multicenter study of iparomlimab (QL1604) in patients (pts) with unresectable/metastatic deficient mismatch repair (dMMR)/microsatellite instability high (MSI-H) solid tumors

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

机构： [1]Department of Gastrointestinal Medical Oncology, Fudan University Shanghai CancerCenter, Shanghai, China [2]Department of Abdominal Oncology, West China School ofMedicine/West China Hospital of Sichuan University, Chengdu, China [3]ColorectalSurgery, Yunnan Cancer Hospital & The third Affiliated Hospital of Kunming MedicalUniversity & Yunnan Cancer Center, Kunming, China [4]Internal Medicine Department,Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou,China [5]Internal Medicine Gastroenterology Department, Shandong Cancer HospitalAffiliated to Shandong University, Jinan, China [6]Gastroenterology Department, ShanxiCancer Hospital, Taiyuan, China [7]Oncology Department, Central Hospital Affiliated toShandong First Medical University, Jinan, China [8]Oncology Department, AffiliatedHospital of Jiangnan University, Wuxi, China [9]Surgical Oncology, The First AffiliatedHospital of Bengbu Medical College, Bengbu, China [10]Oncology Department, AnhuiProvincial Cancer Hospital, Hefei, China [11]Gastroenterology Department, The FourthHospital of Hebei Medical University/ Hebei Cancer Hospital, Shijiazhuang, China [12]Gastrourology Department, Hunan Cancer Hospital, Changsha, China [13]ClinicalResearch Center, Qilu Pharmaceutical Co., Ltd., Jinan, China

出处：

DOI：

ISSN：

基金：

语种：

WOS：

中科院分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2023]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

影响因子： 56.7 最新[2023版] 38.2 最新五年平均 56.7 出版当年[2023版] 38.2 出版当年五年平均 50.5 出版前一年[2022版]

第一作者：

第一作者机构： [1]Department of Gastrointestinal Medical Oncology, Fudan University Shanghai CancerCenter, Shanghai, China

推荐引用方式(GB/T 7714)：

APA：

MLA：